Treatment of adenoviral conjunctivitis with topical cidofovir.
Gordon
Y J
YJ
Naesens
L
L
DeClercq
E
E
Maudgal
P C
PC
Veckeneer
M
M
D000258:Adenovirus Infections, Human / Q000188:drug therapy*; D000260:Adenoviruses, Human / Q000302:isolation & purification; D000287:Administration, Topical; D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000077404:Cidofovir; D003228:Conjunctiva / Q000821:virology; D003236:Conjunctivitis, Viral / Q000188:drug therapy*; D003596:Cytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012651:Self Medication
D000998:Antiviral Agents; D009883:Ophthalmic Solutions; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir